Latest News

Explore how differences in portfolio strategy set these two popular dividend ETFs apart for income investors.

It's always a great time to buy quality dividend stocks.

A big day for XRP investors is coming up in February.

As a leading wholesale mortgage lender, UWM Holdings saw significant insider selling amid a challenging year for its share price.

Investing in quality businesses is key.

If you're thinking about claiming Social Security in 2026, you need a solid strategy to make sure you're optimizing your benefits.

Short-term pullbacks will continue to be potential buying opportunities with the 50-day EMA at the 25,208 level offering support right along with the 25,000 level.

Millionaires live below their means, build income streams, and invest like clockwork. Here's how to copy the habits that build real wealth.

Pricing is not the only issue for Beyond Meat.

n late June, the Oracle of Omaha announced that he is stepping down as the CEO of Berkshire; Combs, one of the two long-serving investment managers considered a possible successor to Buffett, left the company to join JPMorgan Chase & Co.

Fuelled by expectations that the demand for copper—a key metal in electrification—will exceed supply, the metal is set to record its largest annual gain since 2009.

Upstart has been a very volatile stock to own, while American Express trades near record territory.

Social Security's work rules are changing in 2026, and the news isn't all good.

Big Tech's biggest players, including Meta, Apple and OpenAI, stumbled in 2025 as botched live demos, unpopular product decisions, an underwhelming GPT-5 launch and massive cloud outages exposed growing gaps between industry hype and real-world execution.

The company disclosed the terms and timeline of an SPV arrangement tied to its Oz-V development program.

These stocks have increased dividends annually for more than half a century.

Bitcoin (CRYPTO: BTC) is poised to end 2025 lower, reversing

Political upheaval is spreading and intensifying, maybe presenting an opportunity, but either way, it is, by far, the greatest risk the world faces in 2026.

Lululemon’s net revenue from the U.S. region fell 2% in its Q3 earnings due to slowing consumer demand amid macro uncertainties.

AXS-12 is being developed to treat cataplexy in narcolepsy by targeting norepinephrine and dopamine activity in the brain.

Here are three stocks -- including a turnaround, a growth story, and a high-yield play -- that investors will want to dig into this new year.